drugset / Trial / NCT02241395
Cell Therapy as Treatment for Cerebral Palsy
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study was to study the effect of autologous bone marrow mononuclear cells on common symptoms of cerebral palsy patients.
Timeline
- Start
- 2013-08
- Primary completion
- 2018-06
- Completion
- 2018-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | autologous bone marrow mononuclear cells | Cell therapy | — | Intrathecal |